In a variety of tumor types, including GICs, a high expression of ABC transporter genes (mainly including MDR1/P-gp, MRP1) can expel chemotherapy drugs out of cancer cells, leading to drug resistance, thus accelerating cell survival and tumor recurrence [142]. This evidence concerns the gene ABCG2 and neoplasm.